Jump to content

Weekly Clip Report August 27


LaurenH

Recommended Posts

Posted

Here is the weekly clip report:
 
BioSpace
“Drs. Kellie Smith, Jeffrey Thompson, and Edwin Yau receive prestigious LUNGevity 2018 Career Development Awards”
https://www.biospace.com/article/releases/drs-kellie-smith-jeffrey-thompson-and-edwin-yau-receive-prestigious-lungevity-2018-career-development-awards/
 
Cure Today
“FDA Grants Full Approval for Keytruda Combination in Lung Cancer”
https://www.curetoday.com/articles/fda-grants-full-approval-for-keytruda-combination-in-lung-cancer
 
Immuno-Oncology News 
“FDA Approves Opdivo for Certain Patients with Advanced Non-Small Cell Lung Cancer”
https://immuno-oncologynews.com/2018/08/21/immunotherapy-opdivo-fda-approved-some-small-cell-lung-cancer-patients/
 
OncLive
“Dr. Pacheco on Second-LineTherapy for ALK+NSCLC”
https://www.onclive.com/onclive-tv/dr-pacheco-on-secondline-therapy-for-alk-nsclc
 
Radiology Business 
“Fox Chase Cancer Center receives $673K from U.S. Department of Defense to improve lung cancer screening”
https://www.radiologybusiness.com/topics/healthcare-economics/lung-cancer-screening-grant-fox-chase-cancer-center
 
OncLive
“Dr. Hall on Combination Approaches in Advanced NSCLC”
https://www.onclive.com/onclive-tv/dr-hall-on-combination-approaches-in-advanced-nsclc
 
OncLive
“Dr. Camidge on the KEYNOTE-024 Trial in NSCLC”
https://www.onclive.com/onclive-tv/dr-camidge-on-the-keynote024-trial-in-nsclc
 
Healio
“FDA approves cobas EGFR Mutation Test for use with Iressa in lung cancer”
https://www.healio.com/hematology-oncology/lung-cancer/news/online/{6d6095e8-01bc-426f-8a15-f8116e28847a}/fda-approves-cobas-egfr-mutation-test-for-use-with-iressa-in-lung-cancer
 
Mayo Clinic News Network
“Q&A: Lung cancer symptoms and prevention”
https://medicalxpress.com/news/2018-08-qa-lung-cancer-symptoms.html
 
OncLive
“Dr. Naidoo on Managing Immune-Related Adverse Events in NSCLC”
https://www.onclive.com/onclive-tv/dr-naidoo-on-managing-immunerelated-adverse-events-in-nsclc

Archived

This topic is now archived and is closed to further replies.

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.